Gary S. Jacob

Before Friday's market open, Synergy Pharmaceuticals Inc (NASDAQ: SGYP) announced positive data from its first of two Phase 3 trials for clinical constipation-predominant irritable bowel syndrome (IBS-C) drug plecanatide. “We are very pleased with these results,” said Gary S. Jacob,...